3 Longevity ETFs to Buy and Hold

The longevity industry is expected to nearly triple from 2025 to 2035, driven by advances in healthcare technology and AI. Three ETFs offer varying degrees of exposure to this emerging sector: XBI provides broad biotech exposure with 150 companies, BMED offers active management with 50 healthcare innovators, and AGNG focuses specifically on aging population solutions with 90 companies. All three have underperformed the broader market in 2026 YTD, suggesting investors should view them as long-term bets.